Wed, Apr 16, 2014, 5:40 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Canaccord Genuity Group Inc. Message Board

mirror_world_man 124 posts  |  Last Activity: 5 hours ago Member since: Mar 23, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • mirror_world_man by mirror_world_man Jan 21, 2014 11:23 AM Flag

    at this price or wait for the CC. Any comments?

    Sentiment: Strong Buy

  • mirror_world_man mirror_world_man Jan 21, 2014 10:37 AM Flag

    could be a move to drop price to acquire more for less ...interesting is right

    Sentiment: Strong Buy

  • Reply to

    any retail left?

    by mirror_world_man Jan 16, 2014 3:26 PM
    mirror_world_man mirror_world_man Jan 18, 2014 2:40 PM Flag

    my thinking was the results will be presented at a medical conference similar to the ATOMIC roll out. Hence a bit of a delay. I hope I am wrong, delaying the introduction of valuable therapy to these patients so a company can make a bigger splash borders on unethical IMHO. I am also hoping for an interim statement like, "the trial is at its half way point and no major adverse events", kind of thing. Also the PR's said 1st Half of 2014, which I interpret as beyond Q1

    Sentiment: Strong Buy

  • Reply to

    any retail left?

    by mirror_world_man Jan 16, 2014 3:26 PM
    mirror_world_man mirror_world_man Jan 17, 2014 5:09 PM Flag

    The phase IIb Benefit ALS trial finished patient enrolment about 5 weeks ago. In theory it is not too early for some insider interim subjective analysis. Results are to be presented prior to June, despite the software glitch by the 3rd party trial organizers. If data is nice there is rumour of skipping phase III altogether, as the ALS sufferers need access to medicines yesterday...compassionate use may even be possible if a highly significant result is seen.
    OM is also in phase IIb, with the current oral segment needing to be done to determine suitable oral dosing to find plasma concentrations for a phase III trial design, if they decide to proceed with the phase III. The current dosing discovery trial is the first stage of the COSMIC. IMHO that data should be out prior to Benefit ALS. I am being optimistic at the conservative approach to both studies and was thinking some insider trading helped this run up. We will see when the short interest data is out. Nevertheless, I sold a block today EOD and kept another to buy on the next dip. GLTAL's. Please anyone correct me of my comments are incorrect.

    Sentiment: Strong Buy

CF.TO
8.070.14(+1.77%)Apr 16 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.